![]() | Only 14 pages are availabe for public view |
Abstract Chemotherapy is one of the main treatments used to combat cancer. A great number of antitumor compounds are natural products or their derivatives, mainly produced by microorganisms. In particular, streptomycetes are the producers of a large number of natural products with different biological activities, including antitumor properties. These antitumor compounds belong to several structural classes such as anthracyclines, enediynes, indolocarbazoles, isoprenoides, macrolides, nonribosomal peptides and others, and they exert antitumor activity by inducing apoptosis through DNA cleavage mediated by topoisomerase I or II inhibition, mitochondria permeabilization, inhibition of key enzymes involved in signal transduction like proteases, or cellular metabolism and in some cases by inhibiting tumor-induced angiogenesis. Streptomycetes have attracted special attention in the last years for their ability to produce interesting pharmacological lead compounds. This study aimed to evaluate the antitumor activity of metabolites from Streptomyces as antitumor activity using both in vitro and in vivo studies. The Streptomyces were purely isolated from the soil samples that collected from various location in Tamalay Menoufia . Then the Streptomyces were recultured successive times and processed to obtain their extracts. Twenty Streptomyces extracts were obtained. Two isolates of Streptomyces were characterized morphologically, physiologically, biochemically and 16sr RNA and they named Streptomyces Tamalay strain Ag18 and Streptomyces Tamalay strain Ag 20. Twenty four female albino mice were used in the present study. The mice were divided into 4 groups (6 of each). The 1st group was Control, injected subcutaneously with an isotonic saline solution. The 2nd, group injected subcutaneously with Ehrlich ascites tumor cells (EAC). |